Title |
An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment
|
---|---|
Published in |
PLOS ONE, January 2012
|
DOI | 10.1371/journal.pone.0029862 |
Pubmed ID | |
Authors |
Sophie Thiolloy, James R. Edwards, Barbara Fingleton, Daniel B. Rifkin, Lynn M. Matrisian, Conor C. Lynch |
Abstract |
Breast to bone metastases frequently induce a "vicious cycle" in which osteoclast mediated bone resorption and proteolysis results in the release of bone matrix sequestered factors that drive tumor growth. While osteoclasts express numerous proteinases, analysis of human breast to bone metastases unexpectedly revealed that bone forming osteoblasts were consistently positive for the proteinase, MMP-2. Given the role of MMP-2 in extracellular matrix degradation and growth factor/cytokine processing, we tested whether osteoblast derived MMP-2 contributed to the vicious cycle of tumor progression in the bone microenvironment. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 2% |
Nigeria | 1 | 2% |
Unknown | 42 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 18% |
Researcher | 6 | 14% |
Professor | 5 | 11% |
Professor > Associate Professor | 5 | 11% |
Student > Master | 4 | 9% |
Other | 7 | 16% |
Unknown | 9 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 19 | 43% |
Medicine and Dentistry | 7 | 16% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Immunology and Microbiology | 1 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 2 | 5% |
Unknown | 12 | 27% |